Systemic administration of imiquimod as an adjuvant improves immunogenicity of a tumor-lysate vaccine inducing the rejection of a highly aggressive T-cell lymphoma-Reference-Cited by-同舟云学术

Systemic administration of imiquimod as an adjuvant improves immunogenicity of a tumor-lysate vaccine inducing the rejection of a highly aggressive T-cell lymphoma

Published:2019-06 Issue: Volume:203 Page:154-161
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Sciullo Paula Di^ORCID,Menay Florencia,Cocozza Federico,Gravisaco María José,Waldner Claudia I.,Mongini Claudia

Funder

Consejo Nacional de Investigaciones Científicas y Tecnicas

CONICET

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference47 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms;Swerdlow;Blood,2016

2. Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment;Kitahara;Ann. Hematol.,2017

3. Antigens for cancer immunotherapy;Neller;Semin. Immunol.,2008

4. Whole tumor antigen vaccines: where are we?;Chiang;Vaccines,2015

5. Imiquimod: modes of action;Bilu;Br. J. Dermatol.,2003

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomedical Applications of Carrageenan;Biopolymers for Biomedical Applications;2024-04-09

2. Heat-killed Mycobacterium tuberculosis induces trained immunity in vitro and in vivo administered systemically or intranasally;iScience;2024-02

3. T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors;Nature Communications;2024-01-02

4. Co-delivering irinotecan and imiquimod by pH-responsive micelle amplifies anti-tumor immunity against colorectal cancer;International Journal of Pharmaceutics;2023-12

5. Vaccine adjuvants: mechanisms and platforms;Signal Transduction and Targeted Therapy;2023-07-19